ESHRE is selective about the research it accepts for presentation, and our presence speaks to the level of expertise of our scientists and partner physicians.
LOS ANGELES, CA (PRWEB)
June 28, 2017
Ovation Fertility continues to maintain its presence in the international market with three research projects accepted for presentation at the 33rd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE). Nearly 10,000 participants – including some of the world’s top thought leaders in reproductive medicine – are expected to attend the event July 2-5 in Geneva, Switzerland.
Ovation Fertility topics include advancements in embryo biopsy techniques and frozen embryo storage, plus advantages of preimplantation genetic screening.
“ESHRE is selective about the research it accepts for presentation, and our presence speaks to the expertise of our scientists and partner physicians,” says Ovation Fertility Chief Executive Officer Nate Snyder. “We are honored to join other top minds at the international level who are bringing about global advancements and innovations in technology that make families possible for people who have struggled with infertility.”
Presentations at Conference
Ovation Fertility will present three posters on its current research:
1. Differential human blastocyst vitrification: A randomized comparative trial assessing solution and device treatments under varying cooling/warming conditions
The vitrification, or freezing, of human embryos for storage has evolved into a highly reliable and efficient process in most assisted reproductive technology laboratories worldwide. Over the past several years, Ovation Fertility Newport Beach Lab Director Mitchel C….